Shares of Novo Nordisk (NVO) plummeted nearly 10% in premarket trading on Monday, November 24th, 2025 following the announcement that its phase 3 clinical trials for an Alzheimer’s […]
Novo Nordisk’s Stock Soars After Dropping Metsera Acquisition Bid
Shares of Novo Nordisk (NVO) surged over 4% in pre-market trading on Monday, November 10, 2025, reaching $46.18 after closing at $45.68 the previous session. The jump came […]
Novo Nordisk Stock Plunges as CEO Steps Down amid Market Headwinds
Danish pharmaceutical giant Novo Nordisk announced that Lars Fruergaard Jørgensen, its CEO, will be stepping down amidst a difficult period marked by escalating competition in the obesity drug […]